Investment Partners, Ltd. Abb Vie Inc. Transaction History

Investment Partners, Ltd.

$222 Million
Q2 2024

A detailed history of Investment Partners, Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Investment Partners, Ltd. holds 17,010 shares of ABBV stock, worth $3.35 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares

17,010

Previous 16,861 0.88%

Holding current value

$3.35 Million

Previous $3.07 Million 4.98%

% of portfolio

1.31%

Previous 1.4%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$154.79 - $180.76 $23,063 - $26,933	149 Added 0.88%	17,010 $2.92 Million
Q1 2024 Apr 15, 2024	BUY	$159.82 - $182.1 $2.13 Million - $2.43 Million	13,319 Added 376.03%	16,861 $3.07 Million
Q4 2023 Feb 02, 2024	BUY	$137.6 - $154.97 $3,027 - $3,409	22 Added 0.63%	3,542 $548,000
Q3 2023 Oct 31, 2023	BUY	$133.59 - $154.65 $189,297 - $219,139	1,417 Added 67.38%	3,520 $524,000
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $424,429 - $528,174	-3,203 Reduced 60.37%	2,103 $283,000
Q1 2023 May 08, 2023	BUY	$144.61 - $166.54 $5,205 - $5,995	36 Added 0.68%	5,306 $845,000
Q4 2022 Jan 17, 2023	SELL	$138.31 - $165.87 $542,313 - $650,376	-3,921 Reduced 42.66%	5,270 $0
Q3 2022 Oct 21, 2022	BUY	$134.21 - $153.93 $535,632 - $614,334	3,991 Added 76.75%	9,191 $1.23 Million
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $4,679 - $5,948	34 Added 0.66%	5,200 $796,000
Q1 2022 Apr 22, 2022	BUY	$131.98 - $163.75 $2,507 - $3,111	19 Added 0.37%	5,166 $838,000
Q4 2021 Feb 04, 2022	BUY	$107.43 - $135.93 $116,131 - $146,940	1,081 Added 26.59%	5,147 $697,000
Q3 2021 Oct 13, 2021	BUY	$106.4 - $120.78 $2,234 - $2,536	21 Added 0.52%	4,066 $439,000
Q2 2021 Jul 15, 2021	SELL	$105.21 - $117.21 $66,282 - $73,842	-630 Reduced 13.48%	4,045 $456,000
Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $478,252 - $526,498	4,675 New	4,675 $506,000
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $188,400 - $221,120	-2,193 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $160,900 - $215,308	2,193 New	2,193 $215,000
Q1 2020 Apr 29, 2020	SELL	$64.5 - $97.79 $147,705 - $223,939	-2,290 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $165,177 - $206,672	2,290 New	2,290 $203,000
Q3 2019 Oct 17, 2019	SELL	$62.98 - $75.72 $522,419 - $628,097	-8,295 Closed	0 $0
Q2 2019 Jul 30, 2019	BUY	$65.7 - $83.98 $56,042 - $71,634	853 Added 11.46%	8,295 $603,000
Q1 2019 May 03, 2019	SELL	$77.14 - $90.79 $5,862 - $6,900	-76 Reduced 1.01%	7,442 $600,000
Q4 2018 Jan 15, 2019	BUY	$77.85 - $96.01 $585,276 - $721,803	7,518 New	7,518 $693,000
Q3 2018 Oct 25, 2018	SELL	$88.91 - $98.84 $689,852 - $766,899	-7,759 Closed	0 $0
Q2 2018 Jul 25, 2018	SELL	$89.78 - $106.23 $19,212 - $22,733	-214 Reduced 2.68%	7,759 $719,000
Q1 2018 May 03, 2018	BUY	$92.01 - $123.21 $195,337 - $261,574	2,123 Added 36.29%	7,973 $755,000
Q4 2017 Jan 31, 2018	BUY	$89.56 - $98.21 $6,000 - $6,580	67 Added 1.16%	5,850 $566,000
Q3 2017 Oct 30, 2017	BUY	$69.85 - $89.22 $403,942 - $515,959	5,783	5,783 $514,000

Others Institutions Holding ABBV

# of Institutions

3,696

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $348B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Investment Partners, Ltd. with notifications on news.

Account

Investment Partners, Ltd. Abb Vie Inc. Transaction History